Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption

LYMPHIRPositive

AI Analysis

Summary

Citius Oncology reports nationwide deployment of expanded commercial and medical affairs teams for LYMPHIR, with full U.S. operational status expected by August 2026.

Importance:3/10

Sentiment:

0.60

commercializationmarket_expansiononcologycommercial_organization

Related Companies

$CTOR

Read the original article

Published by PR Newswire Biotech on July 21, 2026 1:17 PM

Read Original